Dopavision

News

Trial of VR therapy for myopia in kids starts in UK

A therapy for myopia or short-sightedness in children based on virtual reality and a smartphone app is to be tested at UK trial sites.

News

Rare disease, repurposing and the role of AI

Changing Faces: pharma supplier, DTx, and non-profit hires f...

A number of pharma-adjacent tech firms and non-profits announced personnel news in the month of November. We’ve rounded up some highlights below.

News

Dopavision raises €12m for DTx to tackle myopia epidemic

Digital therapeutics (DTx) startup Dopavision has raised funding to develop its lead product, an app designed to slow the progression of myopia – or short-sightedness – in children or adole

Trial of VR therapy for myopia in kids starts in UK

Changing Faces: pharma supplier, DTx, and non-profit hires f...

Dopavision raises €12m for DTx to tackle myopia epidemic

Biosimilars & patient access independent of geographies or s...

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks